These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35497875)

  • 21. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
    Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
    J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
    Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.
    Lin L; Kane N; Kobayashi N; Kono EA; Yamashiro JM; Nickols NG; Reiter RE
    Clin Cancer Res; 2021 Mar; 27(5):1505-1515. PubMed ID: 33219015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
    Jiménez-Cortegana C; Palazón-Carrión N; Martin Garcia-Sancho A; Nogales-Fernandez E; Carnicero-González F; Ríos-Herranz E; de la Cruz-Vicente F; Rodríguez-García G; Fernández-Álvarez R; Rueda Dominguez A; Casanova-Espinosa M; Martínez-Banaclocha N; Gumà-Padrò J; Gómez-Codina J; Labrador J; Salar-Silvestre A; Rodriguez-Abreu D; Galvez-Carvajal L; Provencio M; Sánchez-Beato M; Guirado-Risueño M; Espejo-García P; Lejeune M; Álvaro T; Sánchez-Margalet V; de la Cruz-Merino L; ; ;
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
    Tamadaho RSE; Hoerauf A; Layland LE
    Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.
    Serafini P; Mgebroff S; Noonan K; Borrello I
    Cancer Res; 2008 Jul; 68(13):5439-49. PubMed ID: 18593947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
    Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
    Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
    Telatin V; Nicoli F; Frasson C; Menegotto N; Barbaro F; Castelli E; Erne E; Palù G; Caputo A
    Front Cell Infect Microbiol; 2019; 9():190. PubMed ID: 31259160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
    Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y
    Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer.
    Mesali H; Ajami A; Hussein-Nattaj H; Rafiei A; Rajabian Z; Asgarian-Omran H; Hosseini V; Taghvaei T; Tehrani M
    Iran J Immunol; 2016 Sep; 13(3):167-77. PubMed ID: 27671508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
    Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Österberg B; Lautenbach MJ; Åhlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Sälde J; Albert J; Johansson N; Bell M; Loré K; Färnert A; Smed-Sörensen A
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33492309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.
    Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y
    Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis.
    Wang Y; Tian J; Wang S
    Semin Arthritis Rheum; 2016 Feb; 45(4):490-5. PubMed ID: 26272193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid-Derived Suppressor Cells Confer Infectious Tolerance to Dampen Virus-Induced Tissue Immunoinflammation.
    Sarkar R; Mathew A; Sehrawat S
    J Immunol; 2019 Sep; 203(5):1325-1337. PubMed ID: 31331972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
    Grassi G; Notari S; Gili S; Bordoni V; Casetti R; Cimini E; Tartaglia E; Mariotti D; Agrati C; Sacchi A
    Front Immunol; 2022; 13():842949. PubMed ID: 35572540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
    Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
    Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects.
    Rosado-Sánchez I; De Pablo-Bernal R; Rull A; Gónzalez J; Moreno S; Vinuesa D; Estrada V; Muñoz-Fernández MÁ; Vidal F; Leal M; Pacheco YM
    Front Immunol; 2020; 11():581307. PubMed ID: 33240269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.